Company: ISRG
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001035267-25-000192
Chunk: 67

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 67
---
 not involving trade-ins or lease upgrades312 320 612 604 Ion System Placements**54 74 103 144 **Systems placed under fixed-payment operating lease arrangements (included in total unit placements)13 16 27 42 **Systems placed under usage-based operating lease arrangements (included in total unit placements)21 24 36 37 

41

Product Revenue

Three Months Ended June 30, 2025

Product revenue increased by 21% to $2.05 billion for the three months ended June 30, 2025, compared to $1.69 billion for the three months ended June 30, 2024.

Instruments and accessories revenue increased by 18% to $1.47 billion for the three months ended June 30, 2025, compared to $1.24 billion for the three months ended June 30, 2024. The increase in instruments and accessories revenue was primarily driven by approximately 17% higher da Vinci procedure volume, approximately 52% higher Ion procedure volume, and customer buying patterns. The second quarter 2025 U.S. da Vinci procedure growth was approximately 14%, driven primarily by strong growth in general surgery procedures, most notably cholecystectomy, hernia repair, and appendectomy procedures, as well as growth in gynecological procedures. The number of U.S. da Vinci bariatric procedures performed declined in the high-single digits in the second quarter of 2025 compared to the second quarter of 2024. The second quarter 2025 OUS da Vinci procedure growth was approximately 23%, driven by growth in general surgery procedures, most notably colorectal and hernia repair procedures, urologic procedures, most notably prostatectomy and partial nephrectomy procedures, and gynecologic procedures, most notably hysterectomy procedures. Geographically, the second quarter 2025 OUS da Vinci procedure growth was driven by several markets with particular strength in India and South Korea.

Systems revenue increased by 28% to $575 million for the three months ended June 30, 2025, compared to $448 million for the three months ended June 30, 2024. The higher second quarter 2025 system revenue was primarily driven by an increase in da Vinci system placements, higher operating lease revenue, and higher ASPs in the second quarter of 2025, driven by an increase in da Vinci 5 system placements.

During the second quarter of 2025, 395 da